Henry Koon
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Cutaneous Melanoma Detection and Management
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 40
- CAR-T cell therapy research 16
- Cancer Immunotherapy and Biomarkers 12
- Cutaneous Melanoma Detection and Management 7
- Viral-associated cancers and disorders 6
-
- Melanoma and MAPK Pathways 11
- Co-authors
- Christopher L. Carpenter (3 shared papers)Gregor Cicchetti (2 shared papers)Francisca Vázquez (2 shared papers)Hiroaki Onda (2 shared papers)Hongbing Zhang (2 shared papers)David J. Kwiatkowski (2 shared papers)Michael B. Atkins (11 shared papers)Bruce J. Dezube (7 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Cancer Research (4 papers)Journal of Immunotherapy (3 papers)Current Opinion in Oncology (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Henry Koon
59 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 98
- Oncology 1.3k
- Immunology 845
- Molecular Biology 1.3k
- Physiology 428
- Cancer Research 215
Countries citing papers authored by Henry Koon
This map shows the geographic impact of Henry Koon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Koon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Koon more than expected).
Fields of papers citing papers by Henry Koon
This network shows the impact of papers produced by Henry Koon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Koon. The network helps show where Henry Koon may publish in the future.
Co-authors
The 25 scholars most cited alongside Henry Koon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 437 | |
| 2 | 2003 | 420 | |
| 3 | 2019 | 185 | |
| 4 | 2003 | 179 | |
| 5 | 2006 | 134 | |
| 6 | 2007 | 131 | |
| 7 | 2004 | 126 | |
| 8 | 2003 | 123 | |
| 9 | 2014 | 121 | |
| 10 | 2005 | 103 | |
| 11 | 2017 | 89 | |
| 12 | 2013 | 79 | |
| 13 | 2020 | 72 | |
| 14 | 2007 | 64 | |
| 15 | 2011 | 60 | |
| 16 | 2016 | 53 | |
| 17 | 2010 | 49 | |
| 18 | 2017 | 44 | |
| 19 | 2009 | 38 | |
| 20 | 2019 | 37 |
About Henry Koon
Henry Koon is a scholar working on Oncology, Molecular Biology, Immunology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 3.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Cancer Immunotherapy and Biomarkers (12 papers), Immunotherapy and Immune Responses (11 papers), Melanoma and MAPK Pathways (11 papers), Immune Cell Function and Interaction (10 papers), Cutaneous Melanoma Detection and Management (7 papers), Viral-associated cancers and disorders (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (845 citations), Molecular Biology (1.3k citations), Physiology (428 citations) and Cancer Research (215 citations). Henry Koon has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Christopher L. Carpenter, Gregor Cicchetti, Francisca Vázquez, Hiroaki Onda, Hongbing Zhang, David J. Kwiatkowski, Michael B. Atkins, Bruce J. Dezube, Alison H. Banham and Philip W. Tucker. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal of Immunotherapy, Current Opinion in Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.